KPAX-002

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameKPAX-002
Drug Alias NameKPAX-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors modulatorsCentral nervous system stimulants
TargetsAdrenergic receptors
Therapy Area/IndicationsPersian Gulf Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesK-Pax Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesK-Pax Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPersian Gulf Syndrome

Other Information

ATC CodeN/A
Related LinksN/A